SANOFI3,109.80

Sanofi India Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹7,153 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/12/2022
FY24
31/12/2023
FY25
31/12/2024
Revenue from Operations2,770.12,851.12,013.2
Other Income71.565.316.5
Total Income2,916.42,029.7
Expenses
+ Cost of Materials Consumed549.7564.4354.8
+ Purchases of Stock-in-Trade651.0929.0564.3
+ Changes in Inventories-292.460.2
+ Employee Benefit Expense405.9370.6240.2
+ Finance Costs1.71.5
+ Depreciation & Amortisation41.939.636.7
+ Other Expenses470.2475.8302.9
Total Expenses2,088.71,560.6
EBITDA834.7803.7490.8
EBIT792.8764.1454.1
Profit
PBT before Exceptional Items827.7469.1
+ Exceptional Items132.017.8-37.7
Pretax Income864.3845.5431.4
+ Current Tax245.2243.3125.8
+ Deferred Tax-0.7-8.1
Tax Expense242.6117.7
Net Income602.9413.3
+ Net Income — Continuing Ops602.9313.7
+ Net Income — Discontinued Ops0.099.6
+ Other Comprehensive Income-1.37.2
Total Comprehensive Income621.1601.6420.5
Per Share
Basic EPS261.78179.46
Diluted EPS261.78179.46
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.0131.0
+ Tax — Discontinued Operations0.031.4
Other Comprehensive Income — detail
+ Items NOT to be Reclassified to P&L-1.8
+ Tax on Items NOT to be Reclassified — alt tag-0.5-9.6
+ Tax on Items to be Reclassified — alt tag2.4
Per Share — as-filed variants
Basic EPS — Continuing Operations261.78136.21
Diluted EPS — Continuing Operations261.78136.21
Basic EPS — Discontinued Operations0.0043.25
Diluted EPS — Discontinued Operations0.0043.25
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,569.41,650.11,033.9
Gross Margin %56.6557.8851.36
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)827.7469.1
− Exceptional Items (reconciliation)132.017.8-37.7
Net Income Adj (tax-effected)590.2440.7
EPS Adj256.27191.36
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.00
Paid Up Equity Capital23.023.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.